Academic Journal
Insights on geroscience pre-clinical and clinical trials to promote healthy aging from the Intrinsic Capacity, Frailty and Sarcopenia Research Task Force 2025.
| Τίτλος: | Insights on geroscience pre-clinical and clinical trials to promote healthy aging from the Intrinsic Capacity, Frailty and Sarcopenia Research Task Force 2025. |
|---|---|
| Συγγραφείς: | Tagliafico L; Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. Electronic address: luca.tagliafico@unige.it., Canevelli M; Department of Human Neuroscience, Sapienza University, Rome, Italy; Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden., Barreto PS; IHU HealthAge, Toulouse, France; Institute on Aging, Toulouse University Hospital (CHU Toulouse), Toulouse, France; CERPOP, UMR 1295, Université Paul Sabatier, Toulouse, France., Cesari M; Child, Adolescent and Older People Unit, Department of Sexual, Reproductive, Maternal, Child, Adolescent and Ageing Health, World Health Organization, Geneva, Switzerland., Ferrucci L; Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA., Vellas B; IHU HealthAge, Toulouse, France; Institute on Aging, Toulouse University Hospital (CHU Toulouse), Toulouse, France; CERPOP, UMR 1295, Université Paul Sabatier, Toulouse, France., Rolland Y; IHU HealthAge, Toulouse, France; Institute on Aging, Toulouse University Hospital (CHU Toulouse), Toulouse, France; CERPOP, UMR 1295, Université Paul Sabatier, Toulouse, France. |
| Συλλογικό Έργο: | ICFSR Task Force |
| Πηγή: | The Journal of frailty & aging [J Frailty Aging] 2026 Apr; Vol. 15 (2), pp. 100147. Date of Electronic Publication: 2026 Mar 19. |
| Τύπος έκδοσης: | Journal Article; Review |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Serdi Edition Country of Publication: United States NLM ID: 101604797 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2260-1341 (Print) Linking ISSN: 22601341 NLM ISO Abbreviation: J Frailty Aging Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Toulouse : Serdi Edition |
| Ιατρικοί όροι (MeSH): | Sarcopenia*/therapy , Healthy Aging*/physiology , Geroscience*/methods , Frailty*, Aging/physiology ; Humans ; Clinical Trials as Topic ; Advisory Committees ; Biomarkers ; Aged |
| Περίληψη: | The Intrinsic Capacity, Frailty and Sarcopenia Research (ICFSR) Task Force convened in March 2025 to discuss geroscience-oriented pre-clinical and clinical trials aimed at promoting healthy aging. Key topics included the use of aging biomarkers in clinical trials, senotherapeutics, metabolism-targeting medications, and therapeutic strategies beyond pharmacological approaches. The discussions highlighted the growing interest in, and accumulating evidence for, geroscience interventions. Several future challenges were identified, including the need for a deeper understanding of the biology of aging and the validation of aging biomarkers against relevant clinical outcomes, such as frailty and intrinsic capacity. Furthermore, to accelerate innovation in the field, there is a need to enhance clinical trial methodologies and harmonization-for example, by defining a minimum common dataset of biological, physiological, and clinical factors for geroscience clinical studies-and to foster a paradigm shift, particularly among regulatory authorities. (Copyright © 2026. Published by Elsevier Masson SAS.) |
| Competing Interests: | Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Given their role as Editor-in-Chief and Honorary Editor-in-Chief of the Journal of Frailty & Aging, Marco Canevelli and Matteo Cesari were not involved in the peer review of this article and had no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to another journal Editor. Luca Tagliafico reports to be funded by the Nutrition Research Grant 2025 provided by Nestlé Health Science. Philipe de Souto Barreto reports a relationship with Pfizer that includes funding grants. Luigi Ferrucci reports a relationship with the National Institute on Aging Intramural Research Program. The other Authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The following ICFSR Task Force members are affiliated with or employees of industrial partners: Albert Higgins-Chen: TruDiagnostic; Amos Baruch: Calico Life Sciences; Alexander Casdin and Micah Webster: Empirium Bio; Bashayer Al-Mubarak: Hevolution Foundation; Claire Bigot: Physiogenex; Dobri Kiprov: Global Apheresis Inc. and Circulate; Felipe Sierra: Hevolution Foundation; Gustavo Duque: TSI Pharmaceuticals; Jeroen Aerssens: Rejuvenate Biomed; Jerome Feige: Nestlé Research; John Groarke and Michelle Rossulek: Pfizer Inc.; John Newman: Component Health; Selah Therapeutics, Junevity; Jose Maria Lopez Pedrosa and Suzette Pereira: Abbott Nutrition;Kevin Slawin: Senotherapeutix, Inc.; Leigh Macconell: Hightide Therapeutics; Leila Hicheur and Serge Da Mariana: Groupe IRCEM; Mahajan Ravi: Apollo Hospitals Group; Michelle Rossulek: Pfizer Inc.; Núria Barcons and Stefanie Rau: Nestlé Health Science; Yuta Lee: Accelerated Biosciences. |
| References: | Neural Regen Res. 2026 Mar 1;21(3):1106-1107. (PMID: 39995063) J Nutr Health Aging. 2024 Sep;28(9):100329. (PMID: 39137624) Cell Metab. 2024 Aug 6;36(8):1779-1794.e4. (PMID: 39059384) Nat Commun. 2024 Jun 13;15(1):5046. (PMID: 38871717) Geroscience. 2023 Oct;45(5):2769-2783. (PMID: 37801202) Nat Med. 2024 Sep;30(9):2605-2612. (PMID: 38956196) J Am Geriatr Soc. 2022 Apr;70(4):1082-1094. (PMID: 34951697) Nat Aging. 2025 Mar;5(3):376-385. (PMID: 39900648) J Gerontol A Biol Sci Med Sci. 2013 Apr;68(4):447-55. (PMID: 23051977) J Clin Endocrinol Metab. 2023 Jul 14;108(8):1968-1980. (PMID: 36740954) Annu Rev Nutr. 2017 Aug 21;37:51-76. (PMID: 28826372) Cell Rep Med. 2025 Feb 18;6(2):101968. (PMID: 39933528) NPJ Aging. 2024 Feb 6;10(1):12. (PMID: 38321020) Geroscience. 2026 Apr;48(2):2013-2027. (PMID: 41102476) Geroscience. 2024 Apr;46(2):2409-2424. (PMID: 37987886) Lancet. 2015 Jun 6;385(9984):2255-63. (PMID: 25771249) Nat Aging. 2025 Jul;5(7):1207-1216. (PMID: 40467932) J Frailty Aging. 2021;10(3):196-201. (PMID: 34105701) Front Aging Neurosci. 2025 Mar 04;17:1555872. (PMID: 40103928) J Gerontol A Biol Sci Med Sci. 2016 Jul;71(7):841-9. (PMID: 27208895) Cell. 2023 Jan 19;186(2):243-278. (PMID: 36599349) Aging Cell. 2024 Jan;23(1):e14034. (PMID: 38038340) Aging Clin Exp Res. 2025 Apr 17;37(1):125. (PMID: 40244306) J Frailty Aging. 2022;11(4):342-347. (PMID: 36346720) J Am Geriatr Soc. 2020 Dec;68(12):2805-2813. (PMID: 32822081) Aging Cell. 2014 Jun;13(3):468-77. (PMID: 24341993) Cell Metab. 2017 Sep 5;26(3):539-546.e5. (PMID: 28877457) Cell Chem Biol. 2025 Jan 16;32(1):174-191.e8. (PMID: 39626664) J Am Nutr Assoc. 2025 Feb;44(2):166-179. (PMID: 39384179) Aging Cell. 2025 Feb;24(2):e14399. (PMID: 39644167) Ageing Res Rev. 2022 Nov;81:101743. (PMID: 36206857) Nat Med. 2024 Feb;30(2):360-372. (PMID: 38355974) Microorganisms. 2025 Jun 13;13(6):. (PMID: 40572269) Ageing Res Rev. 2020 Nov;63:101136. (PMID: 32798771) Geroscience. 2025 Feb;47(1):1123-1138. (PMID: 39120687) Epigenetics. 2024 Dec;19(1):2360160. (PMID: 38820227) Science. 2024 Jun 21;384(6702):1300-1301. (PMID: 38900869) J Adv Nurs. 2025 Sep;81(9):5925-5936. (PMID: 40195235) Aging Cell. 2024 Nov;23(11):e14289. (PMID: 39102875) J Gerontol A Biol Sci Med Sci. 2023 Jan 26;78(1):90-96. (PMID: 35182418) Nature. 2024 May;629(8010):154-164. (PMID: 38649488) JAMA. 2018 Oct 2;320(13):1323-1324. (PMID: 30242384) JAMA. 2020 Nov 10;324(18):1855-1868. (PMID: 33170239) Osteoarthritis Cartilage. 2023 Dec;31(12):1567-1580. (PMID: 37544583) Endocr Rev. 2023 Nov 9;44(6):1047-1073. (PMID: 37364580) Aging (Albany NY). 2017 Feb 14;9(2):419-446. (PMID: 28198702) Mol Aspects Med. 2024 Dec;100:101322. (PMID: 39591800) J Frailty Aging. 2025 Feb;14(1):100010. (PMID: 39855889) Aging Cell. 2025 Aug;24(8):e70103. (PMID: 40424097) Stem Cell Res Ther. 2023 Apr 15;14(1):91. (PMID: 37061744) Nat Aging. 2025 Jan;5(1):87-98. (PMID: 39702725) Biomedicines. 2023 Jul 14;11(7):. (PMID: 37509633) Aging Cell. 2025 Jan;24(1):e14354. (PMID: 39444093) Nat Aging. 2022 Jul;2(7):580-591. (PMID: 37117782) Nat Aging. 2023 Dec;3(12):1474-1479. (PMID: 37985720) Ageing Res Rev. 2023 Jun;87:101908. (PMID: 36905962) Mech Ageing Dev. 2021 Sep;198:111548. (PMID: 34352325) J Nutr Health Aging. 2025 Jan;29(1):100401. (PMID: 39743381) J Gerontol A Biol Sci Med Sci. 2025 Apr 7;80(5):. (PMID: 39708300) Geroscience. 2022 Dec;44(6):2701-2720. (PMID: 35999337) J Frailty Aging. 2020;9(1):4-8. (PMID: 32150207) Cell Metab. 2017 Sep 5;26(3):547-557.e8. (PMID: 28877458) Aging Cell. 2025 May;24(5):e14489. (PMID: 39823170) Nat Commun. 2023 Aug 19;14(1):5038. (PMID: 37598227) JAMA Netw Open. 2021 Nov 1;4(11):e2134427. (PMID: 34817584) Ageing Res Rev. 2025 Jul;109:102760. (PMID: 40318767) Aging Cell. 2024 Dec;23(12):e14326. (PMID: 39354697) J Gerontol A Biol Sci Med Sci. 2025 Aug 23;80(9):. (PMID: 40729272) Nat Aging. 2025 Oct;5(10):1926-1929. (PMID: 40926125) Cell Mol Immunol. 2023 Jun;20(6):626-650. (PMID: 37095295) J Gerontol A Biol Sci Med Sci. 2025 Feb 10;80(3):. (PMID: 39549299) Cell. 2023 Aug 31;186(18):3758-3775. (PMID: 37657418) Sci Transl Med. 2014 Dec 24;6(268):268ra179. (PMID: 25540326) Stem Cell Res Ther. 2025 Mar 07;16(1):122. (PMID: 40055739) JAMA. 2025 Aug 26;334(8):681-691. (PMID: 40720610) Aging Cell. 2020 Apr;19(4):e13124. (PMID: 32196924) |
| Substance Nomenclature: | 0 (Biomarkers) |
| Entry Date(s): | Date Created: 20260321 Date Completed: 20260711 Latest Revision: 20260813 |
| Update Code: | 20260813 |
| PubMed Central ID: | PMC13010422 |
| DOI: | 10.1016/j.tjfa.2026.100147 |
| PMID: | 41863810 |
| Βάση Δεδομένων: | MEDLINE |
| ISSN: | 2260-1341 |
|---|---|
| DOI: | 10.1016/j.tjfa.2026.100147 |